Clinuvel Pharmaceuticals Ltd banner

Clinuvel Pharmaceuticals Ltd
OTC:CLVLY

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
OTC:CLVLY
Watchlist
Price: 7.6 USD -3.31% Market Closed
Market Cap: $392m

Wall Street
Price Targets

CLVLY Price Targets Summary
Clinuvel Pharmaceuticals Ltd

Wall Street analysts forecast CLVLY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLVLY is 18.92 USD with a low forecast of 10.15 USD and a high forecast of 32.1 USD.

Lowest
Price Target
10.15 USD
34% Upside
Average
Price Target
18.92 USD
149% Upside
Highest
Price Target
32.1 USD
322% Upside
Clinuvel Pharmaceuticals Ltd Competitors:
Price Targets
WLFC
Willis Lease Finance Corp
-18% Downside
MEDP
Medpace Holdings Inc
30% Upside
FBIZ
First Business Financial Services Inc
18% Upside
LVS
Las Vegas Sands Corp
24% Upside

Revenue
Forecast

31% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
31% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

For the last 14 years the compound annual growth rate for Clinuvel Pharmaceuticals Ltd's revenue is 31%. The projected CAGR for the next 3 years is 15%.

Operating Income
Forecast

N/A
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is 13%.

Net Income
Forecast

N/A
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
N/A
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLVLY's stock price target?
Price Target
18.92 USD

According to Wall Street analysts, the average 1-year price target for CLVLY is 18.92 USD with a low forecast of 10.15 USD and a high forecast of 32.1 USD.

What is Clinuvel Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
15%

For the last 14 years the compound annual growth rate for Clinuvel Pharmaceuticals Ltd's revenue is 31%. The projected CAGR for the next 3 years is 15%.

What is Clinuvel Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
13%

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is 13%.

What is Clinuvel Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
17%

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is 17%.

Back to Top